Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial
Open Access
- 1 September 2016
- journal article
- research article
- Published by Elsevier in The Lancet Gastroenterology & Hepatology
- Vol. 1 (1) , 15-24
Abstract
No abstract availableKeywords
Funding Information
- NIHR Health Technology Assessment programme (project number 06/78/03)
This publication has 27 references indexed in Scilit:
- Outcomes of salvage therapy for steroid-refractory acute severe ulcerative colitis: ciclosporin vs. infliximabAlimentary Pharmacology & Therapeutics, 2013
- Infliximab or cyclosporine for acute severe ulcerative colitis: A retrospective analysisJournal of Gastroenterology and Hepatology, 2012
- Conventional Medical Management of Inflammatory Bowel DiseaseGastroenterology, 2011
- Generalized method for adaptive randomization in clinical trialsStatistics in Medicine, 2011
- Clinical trial: colectomy after rescue therapy in ulcerative colitis – 3‐year follow‐up of the Swedish‐Danish controlled infliximab studyAlimentary Pharmacology & Therapeutics, 2010
- Infliximab for Induction and Maintenance Therapy for Ulcerative ColitisNew England Journal of Medicine, 2005
- The UK IBDQ—A British version of the inflammatory bowel disease questionnaireJournal of Clinical Epidemiology, 2000
- Cyclosporine in Severe Ulcerative Colitis Refractory to Steroid TherapyNew England Journal of Medicine, 1994
- Quality adjusted survival analysisStatistics in Medicine, 1990
- Cortisone in Ulcerative ColitisBMJ, 1955